title: Using antibodies against P2Y and P2X receptors in purinergic signaling research.
abstract: The broad expression pattern of the G protein-coupled P2Y receptors has demonstrated that these receptors are fundamental determinants in many physiological responses, including neuromodulation, vasodilation, inflammation, and cell migration. P2Y receptors couple either G(q) or G(i) upon activation, thereby activating different signaling pathways. Ionotropic ATP (P2X) receptors bind extracellular nucleotides, a signal which is transduced within the P2X protein complex into a cation channel opening, which usually leads to intracellular calcium concentration elevation. As such, this family of proteins initiates or shapes several cellular processes including synaptic transmission, gene expression, proliferation, migration, and apoptosis. The ever-growing range of applications for antibodies in the last 30 years attests to their major role in medicine and biological research. Antibodies have been used as therapeutic tools in cancer and inflammatory diseases, as diagnostic reagents (flow cytometry, ELISA, and immunohistochemistry, to name a few applications), and in widespread use in biological research, including Western blot, immunoprecipitation, and ELISPOT. In this article, we will showcase several of the advances that scientists around the world have achieved using the line of antibodies developed at Alomone Labs for P2Y and P2X receptors.
authors.affiliation: Alomone Labs Ltd., P.O. Box 4287, Jerusalem, 91042, Israel, dovratbr@alomone.com.
authors.forename: Dovrat
authors.initials: D
authors.lastname: Brass
authors.forename: Melanie R
authors.initials: MR
authors.lastname: Grably
authors.forename: Noemi
authors.initials: N
authors.lastname: Bronstein-Sitton
authors.forename: Ofra
authors.initials: O
authors.lastname: Gohar
authors.forename: Alon
authors.initials: A
authors.lastname: Meir
references.citation: J Neurosci. 2006 Aug 30;26(35):9006-9
references.pmid: 16943557
references.citation: J Immunol. 2009 Oct 1;183(7):4648-56
references.pmid: 19734218
references.citation: J Neurosci. 2007 Aug 1;27(31):8190-201
references.pmid: 17670966
references.citation: J Cell Biol. 2001 Apr 30;153(3):491-501
references.pmid: 11331301
references.citation: Cell Prolif. 2004 Feb;37(1):89-96
references.pmid: 14871239
references.citation: Purinergic Signal. 2005 Dec;1(4):337-47
references.pmid: 18404518
references.citation: J Biol Chem. 2009 Sep 18;284(38):25813-22
references.pmid: 19546214
references.citation: Neuropharmacology. 2006 May;50(6):690-704
references.pmid: 16434064
references.citation: J Biol Chem. 2005 Dec 30;280(52):42952-9
references.pmid: 16269410
references.citation: J Neurochem. 2010 Mar;112(5):1261-72
references.pmid: 20002522
references.citation: Acta Physiol (Oxf). 2010 Jun;199(2):149-60
references.pmid: 20345417
references.citation: Am J Respir Cell Mol Biol. 2000 Jul;23(1):52-61
references.pmid: 10873153
references.citation: J Comp Neurol. 2006 Sep 1;498(1):58-67
references.pmid: 16856176
references.citation: Br J Pharmacol. 2009 Sep;158(1):339-53
references.pmid: 19422377
references.citation: J Biol Chem. 2009 May 15;284(20):13446-13454
references.pmid: 19304656
references.citation: J Physiol. 2007 Oct 15;584(Pt 2):473-88
references.pmid: 17702819
references.citation: J Auton Pharmacol. 1996 Dec;16(6):303-7
references.pmid: 9131403
references.citation: Cereb Cortex. 2011 Apr;21(4):806-20
references.pmid: 20739479
references.citation: J Biol Chem. 2009 Sep 4;284(36):24035-48
references.pmid: 19605353
references.citation: Nature. 2003 Jan 2;421(6918):75-9
references.pmid: 12511957
references.citation: Br J Pharmacol. 2002 Jan;135(2):363-72
references.pmid: 11815371
references.citation: Neuroscience. 2006 Sep 1;141(3):1171-80
references.pmid: 16831517
references.citation: J Biol Chem. 2005 Jul 29;280(30):28142-51
references.pmid: 15937334
references.citation: J Cell Physiol. 2007 May;211(2):410-22
references.pmid: 17186500
references.citation: Neuroscience. 2005;133(4):937-45
references.pmid: 15964486
references.citation: J Biol Chem. 2005 Nov 25;280(47):39050-7
references.pmid: 16186116
references.citation: J Neurosci. 2010 Jun 9;30(23):8042-7
references.pmid: 20534852
references.citation: Neuroscience. 2009 Jun 2;160(4):767-83
references.pmid: 19289154
references.citation: Exp Eye Res. 2008 Aug;87(2):137-46
references.pmid: 18617163
references.citation: Anat Rec A Discov Mol Cell Evol Biol. 2003 Jan;270(1):25-40
references.pmid: 12494487
references.citation: J Neurosci. 2008 Mar 12;28(11):2892-902
references.pmid: 18337420
references.citation: Am J Physiol Gastrointest Liver Physiol. 2005 Nov;289(5):G935-48
references.pmid: 15905416
references.citation: J Appl Physiol (1985). 2006 Sep;101(3):960-70
references.pmid: 16741263
references.citation: Purinergic Signal. 2010 Jun;6(2):231-48
references.pmid: 20806015
references.citation: Free Radic Biol Med. 2010 Aug 1;49(3):416-26
references.pmid: 20447456
references.citation: Immunol Res. 2002;26(1-3):199-206
references.pmid: 12403358
references.citation: Trends Neurosci. 2006 May;29(5):257-62
references.pmid: 16564580
references.citation: Purinergic Signal. 2009 Sep;5(3):327-33
references.pmid: 19347609
references.citation: J Neurosci. 2002 Jan 1;22(1):93-102
references.pmid: 11756492
references.citation: Pflugers Arch. 2006 Aug;452(5):513-37
references.pmid: 16649055
references.citation: Neuropharmacology. 2007 Aug;53(2):257-71
references.pmid: 17612577
references.citation: Platelets. 2010;21(3):153-66
references.pmid: 20201633
references.citation: Hypertension. 2005 Sep;46(3):562-8
references.pmid: 16116048
references.citation: Purinergic Signal. 2009 Jun;5(2):233-40
references.pmid: 19280367
references.citation: Am J Physiol Cell Physiol. 2005 Jun;288(6):C1342-56
references.pmid: 15728711
references.citation: Neuroscience. 2005;136(3):615-23
references.pmid: 16344139
references.citation: Respir Physiol Neurobiol. 2010 Jan 31;170(1):67-75
references.pmid: 19995619
references.citation: Platelets. 2005 Aug;16(5):261-7
references.pmid: 16011976
references.citation: J Mol Cell Cardiol. 2005 Oct;39(4):699-707
references.pmid: 16111700
references.citation: Mol Neurobiol. 2007 Oct;36(2):165-83
references.pmid: 17952660
references.citation: Physiol Rev. 2002 Oct;82(4):1013-67
references.pmid: 12270951
references.citation: J Thromb Haemost. 2003 Feb;1(2):330-6
references.pmid: 12871508
references.citation: Neurochem Int. 2010 Apr;56(5):670-8
references.pmid: 20144676
references.citation: FEBS Lett. 2005 Jul 4;579(17):3783-8
references.pmid: 15978588
references.citation: J Biol Chem. 2001 Nov 2;276(44):41479-85
references.pmid: 11546776
references.citation: J Neurosci. 2008 Oct 29;28(44):11263-8
references.pmid: 18971468
references.citation: Purinergic Signal. 2010 Sep;6(3):297-306
references.pmid: 21103213
references.citation: Bone. 2008 Mar;42(3):516-23
references.pmid: 18093889
references.citation: Neuroscience. 2008 Sep 9;155(4):1262-74
references.pmid: 18625291
references.citation: Mol Pain. 2010 Apr 15;6:21
references.pmid: 20398327
references.citation: Histochem Cell Biol. 2009 Dec;132(6):585-97
references.pmid: 19784665
references.citation: J Neural Transm (Vienna). 2008 Aug;115(8):1165-72
references.pmid: 18506388
references.citation: J Gen Physiol. 2010 Apr;135(4):333-53
references.pmid: 20231374
references.citation: Neurochem Int. 2005 Sep;47(4):235-42
references.pmid: 15964665
references.citation: J Neurochem. 2005 Nov;95(3):630-40
references.pmid: 16135088
references.citation: Am J Physiol Gastrointest Liver Physiol. 2007 Jan;292(1):G223-30
references.pmid: 16920697
references.citation: Cell Signal. 2009 Jan;21(1):120-7
references.pmid: 18948190
references.citation: Invest Ophthalmol Vis Sci. 2006 May;47(5):2161-71
references.pmid: 16639028
references.citation: Circ Res. 2006 Apr 14;98(7):970-6
references.pmid: 16543499
references.citation: J Physiol. 2009 Jul 15;587(Pt 14):3651-63
references.pmid: 19451200
references.citation: Purinergic Signal. 2009 Sep;5(3):299-307
references.pmid: 19274488
references.citation: FASEB J. 2009 Apr;23(4):1153-60
references.pmid: 19050048
references.citation: Eur J Pharmacol. 2010 Dec 15;649(1-3):342-8
references.pmid: 20868665
references.citation: Pflugers Arch. 2007 Jan;453(4):519-29
references.pmid: 17043813
references.citation: Eur J Immunol. 2010 May;40(5):1473-85
references.pmid: 20201036
references.citation: J Mol Med (Berl). 2008 Aug;86(8):937-49
references.pmid: 18545980
references.citation: Am J Physiol Regul Integr Comp Physiol. 2009 Apr;296(4):R1140-8
references.pmid: 19118095
references.citation: Neuropharmacology. 2008 Feb;54(2):375-86
references.pmid: 18063000
references.citation: Am J Pathol. 2000 Jan;156(1):269-78
references.pmid: 10623675
references.citation: J Neurosci. 2006 Jun 7;26(23):6163-71
references.pmid: 16763024
references.citation: J Physiol. 2008 Jul 15;586(14):3307-12
references.pmid: 18499722
references.citation: Bone. 2010 Feb;46(2):355-62
references.pmid: 19781676
references.citation: Drug News Perspect. 2003 Apr;16(3):133-40
references.pmid: 12819811
references.citation: Blood. 2004 Sep 15;104(6):1606-15
references.pmid: 15205259
references.citation: Science. 1996 May 3;272(5262):735-8
references.pmid: 8614837
references.citation: Purinergic Signal. 2010 Jun;6(2):249-61
references.pmid: 20806016
references.citation: Biochim Biophys Acta. 1991 May 24;1074(1):151-8
references.pmid: 2043665
references.citation: J Leukoc Biol. 2009 Jun;85(6):978-86
references.pmid: 19276178
references.citation: Glia. 2009 Nov 15;57(15):1680-90
references.pmid: 19373936
references.citation: Endocrinology. 2009 Jun;150(6):2596-602
references.pmid: 19196799